Search Results 681-690 of 13936 for Assay

  1. Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients - Mayo Clinic

    positive interferon-gamma release assay) - History or evidence of clinically significant cardiovascular, CNS and/or other systemic disease that in the ...

  2. Publications - Hussam Al Kateb, Ph.D. - Mayo Clinic

    Validation of the TruSight Oncology 500 Assay for the Detection and Reporting of Pan- Cancer Biomarkers – The Mayo Clinic Experience (Revised manuscript in ...

  3. A Study To Evaluate Tadalafil And Lenalidomide With Or Without Activated Marrow Infiltrating Lymphocytes (MILs) In High Risk Myeloma - Mayo Clinic

    A positive serum free lite assay is acceptable;; ECOG performance status of 0 - 2 (see Appendix C). Meet all institutional requirements for autologous stem ...

  4. Living-Donor Kidney Transplant Clinical Trials - Mayo Clinic Research

    The purpose of this study is to validate the use of an RNA-seq based peripheral blood assay in renal transplant recipients in adult kidney transplant recipients ...

  5. Clinical trials - Oncology (Medical)

    Rochester, Minn. The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different ...

  6. Pancreatitis Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate the lateral flow assay (LFA) to be used in conjunction with imaging and existing biomarkers in diagnosed or at-risk-for ...

  7. Clinical trials - Oncology (Medical)

    The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early- ...

  8. Coronavirus Disease 2019 Clinical Trials - Mayo Clinic Research

    This will be accomplished by utilizing the the immunoSEQ Human T-cell Receptor Beta (hsTCB) Assay (Adaptive Biothechnologies) and the publicly available ...

  9. Clinical trials - Oncology (Medical)

    The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early- ...

  10. Clinical trials - Oncology (Medical)

    The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early- ...